Literature DB >> 18491953

Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application.

Ander Abarrategi1, Carolina Moreno-Vicente, Viviana Ramos, Inmaculada Aranaz, José Vicente Sanz Casado, José Luís López-Lacomba.   

Abstract

Ceramic materials are osteoconductive matrices extensively used in bone tissue engineering approaches. The performance of these types of biomaterials can be greatly enhanced by the incorporation of bioactive agents and materials. It is previously reported that chitosan is a biocompatible, biodegradable material that enhances bone formation. In the other hand, bone morphogenetic protein-2 (BMP-2) is a well-known osteoinductive factor. In this work we coated porous beta-tricalcium phosphate (beta-TCP) scaffolds with recombinant human BMP-2 (rhBMP-2) carrier chitosan films and studied how they could modify the ceramic physicochemical properties, cellular response, and in vivo bone generation. Initial beta-TCP disks with an average diameter of 5.78 mm, 2.9 mm thickness, and 53% porosity were coated with a chitosan film. These coating properties were studied by X-ray diffraction, Fourier transform-infrared analysis, transmission electron microscopy, scanning electron microscopy, and energy dispersive X-ray analysis (EDX). Treatment modified the scaffold porous distribution and increased the average hardness. The biocompatibility did not seem to be altered. In addition, adhered C2C12 cells expressed alkaline phosphatase activity, related to cell differentiation toward osteogenic lineage, due to the incorporation of rhBMP-2. On the other hand, in vivo observations showed new bone formation 3 weeks after surgery, a much shorter time than control beta-TCP ceramics. These results suggest that developed coating improved porous beta-TCP scaffold for bone tissue applications and added osteoinductive properties.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18491953     DOI: 10.1089/ten.tea.2007.0229

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  18 in total

1.  Chitosan coating to enhance the therapeutic efficacy of calcium sulfate-based antibiotic therapy in the treatment of chronic osteomyelitis.

Authors:  Karen E Beenken; James K Smith; Robert A Skinner; Sandra G Mclaren; William Bellamy; M Johannes Gruenwald; Horace J Spencer; Jessica A Jennings; Warren O Haggard; Mark S Smeltzer
Journal:  J Biomater Appl       Date:  2014-05-21       Impact factor: 2.646

2.  Use of OP-1 (rhBMP-7) in posterolateral lumbar arthrodesis.

Authors:  Jetan H Badhiwala; Michael G Fehlings
Journal:  J Spine Surg       Date:  2016-12

3.  The mechanism research of non-Smad dependent TAK1 signaling pathway in the treatment of bone defects by recombination BMP-2-loaded hollow hydroxyapatite microspheres/chitosan composite.

Authors:  Jingtang Li; Shilang Xiong; Linghua Ding; Jianhua Zeng; Peng Qiu; Jianguo Zhou; Xingen Liao; Long Xiong
Journal:  J Mater Sci Mater Med       Date:  2019-11-27       Impact factor: 3.896

4.  Elastomeric osteoconductive synthetic scaffolds with acquired osteoinductivity expedite the repair of critical femoral defects in rats.

Authors:  Tera M Filion; Xinning Li; April Mason-Savas; Jaclynn M Kreider; Steven A Goldstein; David C Ayers; Jie Song
Journal:  Tissue Eng Part A       Date:  2010-10-21       Impact factor: 3.845

Review 5.  Studies of bone morphogenetic protein-based surgical repair.

Authors:  Kevin W-H Lo; Bret D Ulery; Keshia M Ashe; Cato T Laurencin
Journal:  Adv Drug Deliv Rev       Date:  2012-04-02       Impact factor: 15.470

6.  Smart scaffolds in bone tissue engineering: A systematic review of literature.

Authors:  Saeed Reza Motamedian; Sepanta Hosseinpour; Mitra Ghazizadeh Ahsaie; Arash Khojasteh
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

7.  pHEMA-nHA encapsulation and delivery of vancomycin and rhBMP-2 enhances its role as a bone graft substitute.

Authors:  Xinning Li; Jianwen Xu; Tera M Filion; David C Ayers; Jie Song
Journal:  Clin Orthop Relat Res       Date:  2013-08       Impact factor: 4.176

8.  Chitosan-based scaffolds for bone tissue engineering.

Authors:  Sheeny Lan Levengood; Miqin Zhang
Journal:  J Mater Chem B       Date:  2014-06-07       Impact factor: 6.331

9.  Sustained and localized in vitro release of BMP-2/7, RANKL, and tetracycline from FlexBone, an elastomeric osteoconductive bone substitute.

Authors:  Jianwen Xu; Xinning Li; Jane B Lian; David C Ayers; Jie Song
Journal:  J Orthop Res       Date:  2009-10       Impact factor: 3.494

10.  Surface delivery of tunable doses of BMP-2 from an adaptable polymeric scaffold induces volumetric bone regeneration.

Authors:  Michael Bouyer; Raphael Guillot; Jonathan Lavaud; Cedric Plettinx; Cécile Olivier; Véronique Curry; Jean Boutonnat; Jean-Luc Coll; Françoise Peyrin; Véronique Josserand; Georges Bettega; Catherine Picart
Journal:  Biomaterials       Date:  2016-06-29       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.